中药板块9月9日跌0.87%，维康药业领跌，主力资金净流出6.04亿元

Market Overview - On September 9, the traditional Chinese medicine sector declined by 0.87% compared to the previous trading day, with Weikang Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3807.29, down 0.51%, while the Shenzhen Component Index closed at 12510.6, down 1.23% [1] Stock Performance - Weikang Pharmaceutical (300878) closed at 20.49, down 5.05% with a trading volume of 41,700 shares and a turnover of 87.3962 million yuan [2] - Wanbangde (002082) fell by 4.10% to 9.82, with a trading volume of 300,500 shares and a turnover of 298 million yuan [2] - New Tian Pharmaceutical (002873) decreased by 3.80% to 11.39, with a trading volume of 125,900 shares and a turnover of 14.5 million yuan [2] - Other notable declines include Tianmu Pharmaceutical (600671) down 3.51%, Zhendong Pharmaceutical (300158) down 3.14%, and Jiuzhitang (000989) down 2.89% [2] Capital Flow - The traditional Chinese medicine sector experienced a net outflow of 604 million yuan from institutional investors, while retail investors saw a net inflow of 563 million yuan [4] - Notable net inflows from retail investors include Yiling Pharmaceutical (002603) with a net outflow of 63.9047 million yuan from institutional investors and a net inflow of 52.8464 million yuan from retail investors [4] - Other companies with significant capital movements include Ma Yinglong (600993) with a net inflow of 29.999 million yuan from institutional investors and a net outflow of 10.7281 million yuan from retail investors [4]